Conference - Boston, MA, United States
The field of antibodies directed against cancer is burgeoning and this is a huge growth area due to the success of drugs already on the market. There still remain a number of challenges that include reducing immunogenicity, improving the targeting in solid tumors, and increasing the ability to kill cancer cells. The pre-clinical and clinical results of recent new constructs will be shared, and the changes in regulation of antibodies will be reviewed. The latest new approaches will be compared to more established techniques for filling the pipeline with future best-in-class drugs.
![Image02[1] resized 600](http://cdn2.hubspot.net/hub/45279/file-14310073-jpg/images/image02[1]-resized-600.jpg?width=330&height=83&name=image02[1]-resized-600.jpg)
Website: http://www.pegsummit.com/cancer-antibodies
April 30 - May 1, 2012 (8:00 am-6:00 pm)
The Boston Park Plaza Hotel, Boston, MA
Contact: Nilufer Donmez ndonmez@healthtech
Phone: 781-247-6257
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
